STAAR Surgical Co (OQ:STAA)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 04, 2024 07:00 am ET

STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced preliminary net sales for the first quarter ended March 29, 2024, are expected to be in excess of $77 million with U.S. ICL sales expected to be $5 million for the quarter. This represents the Company’s highest quarterly ICL sales in the U.S. since the Company obtained U.S. FDA approval of the EVO ICL in March 2022. The Company is providing this information due to investment community meetings

Apr 02, 2024 07:00 am ET

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, comes to the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Boston from April 5-8, 2024, fresh off the achievement of a new commercial milestone: three million lenses sold. Furthering the momentum behind its flagship product, EVO ICL, the company is proud to showcase the clinical, practice and innovation advantages through a series of posters, presentations and educatio

Mar 18, 2024 07:00 am ET

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

Mar 12, 2024 10:30 am ET

Sidoti Events, LLC's Virtual March Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 13-14, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

Mar 12, 2024 07:00 am ET

STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Arthur Butcher, Executive Vice President and Group President, MedSurg and Asia Pacific for Boston Scientific, and Wei Jiang, retired Executive Vice President and President of Bayer Pharmaceuticals Region China & APAC, to its Board of Directors, effective March 12, 2024.

Mar 06, 2024 07:00 am ET

STAAR Surgical to Participate in Two Upcoming Investor Conferences

Feb 26, 2024 04:01 pm ET

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results

Feb 19, 2024 07:00 am ET

STAAR Surgical to Report Fourth Quarter Results on February 26, 2024

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it will release financial results for the fourth quarter ending December 29, 2023, on Monday, February 26, 2024, after the market close.

Jan 23, 2024 07:00 am ET

STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, and SharpeVision, a premier ophthalmology group with clinics in Seattle, Chicago and Austin, today announced a strategic agreement to provide EVO ICL lenses as a first choice for patients seeking visual freedom from contact lenses and glasses.

Jan 08, 2024 07:00 am ET

STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL) for myopia, astigmatism and presbyopia, today announced preliminary results for the fourth quarter and fiscal year ended December 29, 2023. Preliminary net sales were approximately $76.5 million for the fourth quarter and approximately $322.5 million for fiscal 2023. Operating margin is expected to be approximately 5% for the fourth quarter and fiscal 2023.

Dec 04, 2023 04:05 pm ET

Lilian Zhou Appointed to STAAR Surgical Board of Directors

Nov 15, 2023 07:00 am ET

STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)

Nov 01, 2023 04:01 pm ET

STAAR Surgical Reports Third Quarter 2023 Results

Oct 18, 2023 04:05 pm ET

STAAR Surgical to Report Third Quarter Results on November 1, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the third quarter ended September 29, 2023 on Wednesday, November 1, 2023 after the market close.

Oct 17, 2023 07:00 am ET

STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer® Lens (ICL)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is celebrating the 30th anniversary of its proprietary Implantable Collamer® Lens (ICL). The first ICLs were implanted by a group of surgeons in October 1993, including Roberto Zaldivar, MD, Founder of the Zaldivar Institute. The early ICLs have evolved into the current generation of ICLs with a central port – the EVO ICL™ family of lenses.

Oct 10, 2023 10:51 am ET

Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL

LAKE FOREST, Calif., Oct. 10, 2023 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, is proud to announce a partnership with renowned actor and comedian, Jimmy O. Yang. This partnership brings together EVO Implantable Collamer® Lenses (EVO ICL) for nearsightedness and astigmatism and the voice of Jimmy O. Yang. The EVO ICL vision correction procedure has been a life-changing experience for him.

Sep 14, 2023 07:00 am ET

STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, will host Vision 2026, the Company’s investor day, at the Nasdaq MarketSite in Times Square today. To honor the occasion and celebrate the 40th anniversary of being listed as a public company, Tom Frinzi, Chair of the Board and CEO, along with the company’s executive leadership team and STAAR employees, have been invited to ring the Nasdaq closing bell on Thursday, September 14.

Sep 07, 2023 05:00 pm ET

STAAR Surgical to Host “Vision 2026” Investor Day on September 14, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will host an in-person Investor Day on Thursday, September 14, 2023, beginning at 8:00 a.m. Eastern Time in New York City.

Aug 09, 2023 07:00 am ET

STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced its partnership with Will Levis, quarterback for the Tennessee Titans of the National Football League (NFL). This partnership will raise awareness of the EVO Implantable Colla

Aug 07, 2023 07:00 am ET

STAAR Surgical to Participate in Upcoming Investor Conferences

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that management will participate in several upcoming investor conferences.

Aug 02, 2023 04:01 pm ET

STAAR Surgical Reports Second Quarter 2023 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023.

Jul 19, 2023 07:00 am ET

STAAR Surgical to Report Second Quarter Results on August 2, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the second quarter ended June 30, 2023 on Wednesday, August 2, 2023 after the market close.

Jun 13, 2023 08:00 am ET

Sidoti Events, LLC's Virtual June Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / June 13, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 14-15, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.

May 04, 2023 07:00 am ET

EVO ICL Sponsors Jonas Brothers’ The Tour

EVO ICL, the vision correction procedure that works in harmony with your natural eye, provides sharp, clear vision day or night and does not cause contact lens induced dry eye or dry eye syndrome, announced today sponsorship of the Jonas Brothers’ The Tour in North America, which begins August 12. Collaboration with the group will also include a new EVO advertising campaign slated for launch in the fall of 2023. The campaign will help drive education and awareness of EVO among the millions of Americans who suffer from myopia and are looking for a proven and effective vision correction solution

May 03, 2023 04:01 pm ET

STAAR Surgical Reports First Quarter 2023 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the first quarter ended March 31, 2023.

Apr 19, 2023 07:00 am ET

STAAR Surgical to Report First Quarter Results on May 3, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the first quarter ended March 31, 2023 on Wednesday, May 3, 2023 after the market close.

Mar 29, 2023 07:00 am ET

STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced Warren Foust has been named Chief Operating Officer and Magda Michna, Ph.D., has been named Chief Clinical, Regulatory and Medical Affairs Officer. Both positions will report to STAAR Surgical’s President and CEO, Tom Frinzi.

Feb 21, 2023 04:01 pm ET

STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the fourth quarter and fiscal year ended December 30, 2022.

Feb 07, 2023 07:00 am ET

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended December 30, 2022, on Tuesday, February 21, 2023 after the market close.

Jan 11, 2023 07:00 am ET

Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses, today announced a partnership with actress and beauty entrepreneur, Peyton List, to further its mission of bringing EVO Implantable Collamer® Lenses (EVO) to the millions of Americans who suffer from myo

Jan 09, 2023 07:00 am ET

STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported preliminary sales for the fourth quarter and fiscal year ended December 30, 2022. Preliminary net sales were approximately $64 million for the fourth quarter and approximately $284 million for fiscal 2022. Fiscal 2022 preliminary net sales include approximately $270 million of ICL sales and approximately $14 million of sales from the Other Products business which the Company previously announced is being exited.

Dec 19, 2022 08:15 am ET

STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that President and Chief Executive Officer Caren Mason will be retiring December 31, 2022, after leading the company through a significant period of revitalization and growth for more than seven years. STAAR’s Board of Directors has appointed ophthalmic industry executive Thomas “Tom” G. Frinzi, current Board Chair of STAAR, to serve as President and CEO, effective January 1, 2023.

Nov 17, 2022 07:00 am ET

STAAR Surgical Opens EVO Experience Center in United States

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the opening of the first company-operated EVO Experience Center. The center is located at STAAR’s corporate headquarters in Lake Forest, California within close proximity to Orange County’s John Wayne Airport (SNA).

Nov 02, 2022 04:01 pm ET

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 30, 2022.

Oct 19, 2022 07:00 am ET

STAAR Surgical to Report Third Quarter Results on November 2, 2022

Oct 12, 2022 07:00 am ET

Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced a partnership with professional basketball player Max Strus to further its mission of bringing EVO Implantable Collamer® Lenses (EVO) to the mil

Sep 14, 2022 07:00 am ET

STAAR Surgical Patient Awareness Campaign Launched In New York

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided an update on activities related to the commercial introduction of its EVO Visian® Implantable Collamer® Lenses (EVO) in the U.

Aug 10, 2022 04:03 pm ET

STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced its partnership with singer, songwriter, and actor, Joe Jonas, to raise awareness of its EVO Visian® Implantable Collamer® Lenses

Aug 10, 2022 04:01 pm ET

STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y

Jul 20, 2022 07:00 am ET

STAAR Surgical to Report Second Quarter Results on August 10, 2022

Jun 14, 2022 02:45 pm ET

Sidoti's Summer Small Cap Virtual Conference

NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and Thursday, June 15th-16th, 2022. The links can also be found at www.sidoticonference.com/events.

Jun 07, 2022 07:00 am ET

STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that more than two million Visian® Implantable Collamer lenses (“ICLs”) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses – EVO Visian® ICLs (“EVO”). New to the U.S. market, EVO is available in more than 75 countries around the world.

May 04, 2022 04:01 pm ET

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y

Apr 20, 2022 07:00 am ET

STAAR Surgical to Report First Quarter Results on May 4, 2022

Apr 06, 2022 07:00 am ET

STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the first implants of the EVO Visian® Implantable Collamer® lens (EVO ICL) in the U.S. The Company also announced today its program of meetings and presentations during the American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in Washington, D.C., April 22 through April 26, 2022.

Mar 28, 2022 03:01 am ET

STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the EVO/EVO+ Visian® Implantable Collamer® Lens (“EVO”) for the correction of myopia and myopia with astigmatism. Myopia, which is also known as nearsightedness or the need for distance vision correction, is the most common vision disorder globally and its prevalence is rapidly growing.1 An estimated 100 million U.S. adults ages 21 to 45 who have

Feb 23, 2022 04:01 pm ET

STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results

Feb 09, 2022 07:00 am ET

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2021 on Wednesday, February 23, 2022 after the market close.

Jan 10, 2022 07:00 am ET

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended December 31, 2021. The Company expects total net sales for the fourth quarter to be approximately $59 million and full year net sales to be approximately $230 million. GAAP earnings per share is expected to be approximately $0.10 for the fourth quarter and approximately $0.50 for the fiscal year ended December 31, 2021.

Nov 03, 2021 04:01 pm ET

STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y

Oct 20, 2021 07:00 am ET

STAAR Surgical to Report Third Quarter Results on November 3, 2021

Aug 04, 2021 04:01 pm ET

STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021

Jul 21, 2021 09:15 am ET

STAAR Surgical to Report Second Quarter Results on August 4, 2021

May 05, 2021 04:01 pm ET

STAAR Surgical Reports Record First Quarter 2021 Net Sales of $50.8 Million Up 44% Y/Y

Apr 21, 2021 07:00 am ET

STAAR Surgical to Report First Quarter Results on May 5, 2021

Feb 24, 2021 04:01 pm ET

STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results

Feb 10, 2021 07:00 am ET

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 24, 2021

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 1, 2021 on Wednesday, February 24, 2021 after the market close.

Jan 26, 2021 10:45 am ET

Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth Yeu, M.D., Partner, Virginia Eye Consultants, and K. Peony Yu, M.D., retired Chief Medical Officer, FibroGen Inc., to its Board of Directors, effective January 21, 2021.

Jan 25, 2021 05:35 pm ET

Staar Surgical Set to Join S&P MidCap 400; Prestige Consumer Healthcare & Bridge Bancorp to Join S&P SmallCap 600

NEW YORK, Jan. 25, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:

Jan 10, 2021 06:00 pm ET

STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended January 1, 2021. The Company expects total net sales for the fourth quarter to be approximately $46 million and full year sales to be approximately $163 million. GAAP earnings per share is expected to be approximately $0.06 for the fourth quarter and approximately $0.12 for the fiscal year ended January 1, 2021. The Company expects cash and cash equivalents to be ap

Jan 05, 2021 08:00 pm ET

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Fir

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Peabody Energy Corporation (NYSE: BTU), EQT Corporation (NYSE: EQT), Exela Technologies, Inc. (NASDAQ: XELA), and...

Nov 04, 2020 04:03 pm ET

STAAR Surgical Begins Commercialization of EVO Viva™ Presbyopia Correcting Lens

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the initial commercialization of its EVO Viva™ presbyopia correcting lens including the first patient implant.

Nov 04, 2020 04:01 pm ET

STAAR Surgical Reports Third Quarter 2020 Results

Oct 21, 2020 07:00 am ET

STAAR Surgical to Report Third Quarter Results on November 4, 2020

Oct 19, 2020 11:50 am ET

STAA FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Reminds STAAR Surgical Company Investors of Important October 19 Deadline in Securities Class Action – STAA

Oct 19, 2020 10:00 am ET

STAA FINAL DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds STAAR Surgical Company of Class Action and Encourages Shareholders to Contact the Firm

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and certain of its officers, on behalf of shareholders...

Oct 17, 2020 01:56 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline - STAA

NEW YORK, Oct. 17, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and certain of its officers. The class action, filed in United States District Court for the Central District of California, Southern Division, and docketed under 20-cv-01660, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired STAAR Surgical Company securities between February 26, 2020, and August 10, 2020, inclusive (the "Class Period"), seeking to recove

Oct 16, 2020 03:37 pm ET

STAAR Surgical Company: Last Days to Participate Actively in the Class Action Lawsuit

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of STAAR Surgical Company (NASDAQ: STAA) investors that acquired shares between February 26, 2020 and August 10, 2020. Investors have until October 19, 2020...

Oct 16, 2020 10:45 am ET

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against STAAR Surgical Company (STAA)

The Law Offices of Frank R. Cruz reminds investors of the upcoming October 19, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased STAAR Surgical Company ("STAAR” or the "Company") (NASDAQ:

Oct 14, 2020 11:30 am ET

DEADLINE ALERT for GNUS, AYX, STAA, QTT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Oct 13, 2020 06:00 pm ET

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against STAAR Surgical Company and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors that...

Oct 12, 2020 03:38 pm ET

UPCOMING DEADLINE ALERT: STAAR Surgical Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating securities claims on behalf of investors of STAAR Surgical Company (“STAAR Surgical” or the “Company”) (NASDAQ: STAA) to determine whether STAAR may have issued materially misleading business information to...

Oct 12, 2020 12:00 pm ET

ROSEN, A TOP RANKED LAW FIRM, Reminds STAAR Surgical Company Investors of Important October 19 Deadline in Securities Class Action – STAA

Oct 12, 2020 11:15 am ET

DEADLINE ALERT for AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Oct 12, 2020 11:00 am ET

STAA UPCOMING DEADLINE: Bronstein, Gewirtz & Grossman, LLC Reminds STAAR Surgical Company of Class Action and Encourages Shareholders to Contact the Firm

Oct 12, 2020 08:00 am ET

IMMINENT DEADLINE: STAAR Surgical Company Sued for Securities Fraud by Block & Leviton LLP; Investors Who Lost Money Should Contact the Firm

On August 11, 2020, analyst J Capital Research Limited published a scathing report calling into question the purported success of STAAR Surgical Company (NASDAQ: STAA) in China. In its report, J Capital accused STAAR of overstating its sales in...

Oct 08, 2020 10:58 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline – STAA

Pomerantz LLP announces that a class action lawsuit has been filed against STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) and certain of its officers. The class action, filed in United States District Court for the Central...

Oct 08, 2020 08:00 am ET

STAAR Surgical Company Investors: Portnoy Law Advises Last Days to Participate Actively in the Class Action Lawsuit

Oct 07, 2020 02:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Genius Brands, STAAR Surgical, Baidu, and Alteryx and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Genius Brands International, Inc. (NASDAQ: GNUS), STAAR Surgical Company...

Oct 07, 2020 10:02 am ET

STAA INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Staar Surgical Company

Oct 06, 2020 11:00 am ET

DEADLINE ALERT for GNUS, AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Oct 05, 2020 12:00 pm ET

DEADLINE ALERT for GNUS, AYX, STAA, QTT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Oct 04, 2020 02:32 pm ET

ROSEN, A TOP RANKED LAW FIRM, Reminds STAAR Surgical Company Investors of Important October 19 Deadline in Securities Class Action – STAA

Oct 03, 2020 04:03 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline – STAA

Oct 02, 2020 01:45 pm ET

STAA DEADLINE: Zhang Investor Law Reminds STAAR Surgical Company Investors of Deadline in Securities Class Action – STAA

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover...

Oct 02, 2020 09:00 am ET

Notice of Lead Plaintiff Deadline for Shareholders in the STAAR Surgical Company Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces that a class action lawsuit has been filed in the Central District of California on behalf of purchasers of STAAR Surgical Company (NASDAQ:STAA) common stock between February 26, 2020 and August 10, 2020 (the “Class Period”). The case is captioned Alwazzan v. STAAR Surgical Company, No. 20-cv-01533, and is assigned to Judge James V. Selna. The STAAR Surgical class action lawsuit charges STAAR Surgical and certain of its officers with violations of the Securities Exchange Act of 1934.

Oct 01, 2020 04:55 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds STAAR Surgical (STAA) Investors of Securities Fraud Class Action and Encourages Investors with Losses to Contact the Firm Now

Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: Feb. 26, 2020 – Aug. 10, 2020Lead Plaintiff...

Oct 01, 2020 08:45 am ET

INVESTOR ALERT: STAAR Surgical Company Sued for Securities Fraud by Block & Leviton LLP; Investors Who Lost Money Should Contact the Firm

Sep 30, 2020 02:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Kodak, Genius Brands, and STAAR Surgical and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cabot Oil & Gas Corporation (NYSE: COG), Eastman Kodak Company (NYSE: KODK),...

Sep 30, 2020 11:00 am ET

GNUS, STAA & BIDU Shareholder Update: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Deadlines

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Sep 29, 2020 04:27 pm ET

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against STAAR Surgical Company and Encourages Investors to Contact the Firm Before October 19, 2020

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:

Sep 29, 2020 12:00 pm ET

DEADLINE ALERT for GNUS, AYX, STAA, QTT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Sep 28, 2020 12:20 pm ET

DEADLINE ALERT for GNUS, AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Sep 28, 2020 11:01 am ET

STAA INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Staar Surgical Company

Sep 27, 2020 12:04 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline – STAA

Sep 25, 2020 10:40 am ET

STAA STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against STAAR Surgical Company – STAA

Sep 24, 2020 06:08 pm ET

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against STAAR Surgical Company and Encourages Investors to Contact the Firm Before October 19, 2020

Sep 24, 2020 05:46 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds STAAR Surgical (STAA) Investors of Securities Fraud Class Action and Encourages Investors with Losses to Contact the Firm Now

Sep 23, 2020 03:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against STAAR Surgical, Baidu, Alteryx, and American Electric Power and Encourages Investors to Contact the Fir

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of STAAR Surgical Company (NASDAQ: STAA), Baidu, Inc. (NASDAQ: BIDU), Alteryx, Inc....

Sep 23, 2020 03:00 pm ET

Sidoti & Company Virtual Investor Conference

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Sidoti & Company, LLC has released the presentation schedule, with weblink click-throughs, for Thursday, September 24, 2020, the second day of its two-day Fall 2020 Virtual Investor Conference. For further information about the event, please see www.sidoticonference.com.

Sep 23, 2020 12:30 pm ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against STAAR Surgical Company (STAA)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 19, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) securities...

Sep 23, 2020 11:43 am ET

ROSEN, A RANKED AND LEADING FIRM, Reminds STAAR Surgical Company Investors of Important Deadline in Securities Class Action – STAA

Sep 22, 2020 11:30 am ET

DEADLINE ALERT for AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Sep 22, 2020 10:00 am ET

GNUS, STAA & BIDU Shareholder Update: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines

Attorney Advertising--(PR Newswire)--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links...

Sep 22, 2020 08:00 am ET

SHAREHOLDER ALERT: Block & Leviton LLP Reminds Investors that it Has Filed a Lawsuit Against STAAR Surgical Company for Securities Fraud; Investors Who Lost Money Should Contact the Firm

Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on behalf of shareholders against STAAR Surgical Company (NASDAQ: STAA) and certain of its executives for...

Sep 21, 2020 12:30 pm ET

DEADLINE ALERT for GNUS, AYX, STAA, QTT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Sep 21, 2020 09:47 am ET

STAA INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Staar Surgical Company

Sep 16, 2020 08:45 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline – STAA

Sep 16, 2020 05:04 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds STAAR Surgical (STAA) Investors of Securities Fraud Class Action and Encourages Investors with Losses to Contact the Firm Now

Sep 16, 2020 03:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Kodak, Genius Brands, and STAAR Surgical and Encourages Investors to Contact the Firm

Sep 16, 2020 10:28 am ET

STAA INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Staar Surgical Company

Sep 15, 2020 02:55 pm ET

STAA SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Against Staar Surgical Company

Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that purchased or acquired the common stock of Staar Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) between February 26, 2020, and August 10, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.

Sep 14, 2020 07:10 pm ET

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed Against STAAR Surgical Company and Encourages Investors to Contact the Firm Before October 19, 2020

Sep 14, 2020 01:25 pm ET

ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds STAAR Surgical Company Investors of Important October 19 Deadline in Securities Class Action – STAA

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the “Class Period”) of the important October 19, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for STAAR investors under the federal securities laws.

Sep 14, 2020 11:30 am ET

DEADLINE ALERT for GNUS, AYX, STAA, QTT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Sep 14, 2020 07:00 am ET

STAAR Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trial

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that patient enrollment for the primary study analysis cohort of 300 subjects has been achieved in its U.S. FDA clinical trial, “A Multicenter Clinical Evaluation of the EVO/EVO+ Visian® Implantable Collamer® Lens.” Primary study analysis will be conducted when 300 primary eyes complete 6 months of follow-up, which is anticipated early in the second quarter of 2021 with submission of the study results to the FD

Sep 10, 2020 05:55 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in STAAR Surgical Company of Class Action Lawsuit and Upcoming Deadline – STAA

Sep 10, 2020 03:56 pm ET

ROSEN, A LEADING LAW FIRM, Reminds STAAR Surgical Company Investors of Important Deadline in Securities Class Action – STAA

Sep 10, 2020 11:00 am ET

DEADLINE ALERT for AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Sep 09, 2020 05:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cabot Oil & Gas, Kodak, Genius Brands, and STAAR Surgical and Encourages Investors to Contact the Firm

Sep 09, 2020 11:00 am ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against STAAR Surgical Company (STAA)

Sep 08, 2020 11:50 pm ET

STAAR Surgical Company Investors: Portnoy Law Advises Last Days to Participate Actively in the Class Action Lawsuit

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of STAAR Surgical Company Inc. (NASDAQ: STAA) investors that acquired shares between February 26, 2020 and August 10, 2020. Investors have until October 19,...

Sep 08, 2020 07:15 pm ET

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Announces Filing of Securities Class Action Lawsuit Against STAAR Surgical Company; Encourages Investors with Losses in Excess of $100K to Contact Firm – STAA

Sep 08, 2020 08:00 am ET

LAWSUIT FILED: Block & Leviton LLP Reminds Investors that it Has Filed a Lawsuit Against STAAR Surgical Company for Securities Fraud; Investors Who Lost Money Should Contact the Firm

Sep 07, 2020 12:35 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds STAAR Surgical (STAA) Investors of Securities Fraud Class Action and Encourages Investors with Losses to Contact the Firm Now

Sep 04, 2020 12:30 pm ET

DEADLINE ALERT for GNUS, AYX, STAA, QTT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Sep 02, 2020 05:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Genius Brands, STAAR Surgical, Baidu, and Alteryx and Encourages Investors to Contact the Firm

Sep 02, 2020 07:00 am ET

STAAR Surgical to Participate in Upcoming Investor Conferences

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that management will participate in several upcoming investor conferences. The Company has issued an updated investor presentation it will use during the upcoming meetings, which is available on the Company’s investor website at

Sep 01, 2020 04:33 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages STAAR Surgical (STAA) Investors to Contact Its Attorneys Now, Securities Fraud Case Filed and Application Deadline Approaching

Sep 01, 2020 11:00 am ET

DEADLINE ALERT for AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Aug 31, 2020 11:33 am ET

EQUITY ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against STAAR Surgical Company – STAA

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and August 10, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for STAAR investors under the federal securities laws.

Aug 31, 2020 11:30 am ET

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against STAAR Surgical Company (STAA)

Law Offices of Howard G. Smith reminds investors of the upcoming October 19, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased STAAR Surgical Company ("STAAR” or the "Company") (NASDAQ: STAA) securities between February 26, 2020 and August 10, 2020,

Aug 31, 2020 08:00 am ET

LAWSUIT FILED: Block & Leviton LLP Reminds Investors that it Has Filed a Lawsuit Against STAAR Surgical Company for Securities Fraud; Investors Who Lost Money Should Contact the Firm

Aug 30, 2020 11:00 am ET

ROSEN, A TOP RANKED LAW FIRM, Continues to Investigate Securities Claims Against STAAR Surgical Company; Encourages Investors with Losses in Excess of $100K to Contact the Firm – STAA

Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of STAAR Surgical Company (NASDAQ: STAA) resulting from allegations that STAAR may have issued materially...

Aug 28, 2020 12:00 pm ET

STAA INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies STAAR Surgical Company of Class Action and Encourages Shareholders to Contact the Firm

Aug 28, 2020 11:53 am ET

OCTOBER 19, 2020 DEADLINE ALERT: STAAR Surgical Investors Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.

Aug 26, 2020 07:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against STAAR Surgical, Baidu, Alteryx, and American Electric Power and Encourages Investors to Contact the Fir

Aug 26, 2020 06:12 pm ET

Shareholder Alert: Robbins LLP Announces STAAR Surgical Company (STAA) Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP announces that a purchaser of STAAR Surgical Company (NASDAQ: STAA) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between February 26, 2020 and August 10, 2020. STAAR Surgical designs, develops, manufactures, market

Aug 26, 2020 05:42 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages STAAR Surgical (STAA) Investors to Contact Its Attorneys Now, Securities Fraud Case Filed

Aug 26, 2020 12:00 pm ET

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against STAAR Surgical Company (STAA)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 19, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 26, 2020 10:00 am ET

DEADLINE ALERT for GNUS, AYX, STAA, and QTT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Aug 25, 2020 11:00 am ET

STAA SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies STAAR Surgical Company of Class Action and Encourages Shareholders to Contact the Firm

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired STAAR securities between February 26, 2020 through August 10, 2020, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:

Aug 24, 2020 09:00 am ET

Notice of Lead Plaintiff Deadline for Shareholders in the STAAR Surgical Company Class Action Lawsuit

Aug 21, 2020 04:04 pm ET

STAA INVESTOR ALERT: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Staar Surgical Company

Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action has been filed on behalf of investors that purchased or acquired the common stock of Staar Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) between February 26, 2020, and August 10, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.

Aug 21, 2020 04:00 pm ET

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of STAAR Surgical Company (STAA) Investors

Glancy Prongay & Murray LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 21, 2020 02:32 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages STAAR Surgical (STAA) Investors to Contact Its Attorneys Now, Securities Fraud Case Filed

Aug 21, 2020 01:00 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of STAAR Surgical Company (STAA) Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) securities between February 26, 2020 and August 10, 2020, inclusive (the “Class Period”). STAAR investors have until October

Aug 20, 2020 07:00 pm ET

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action Lawsuit Against STAAR Surgical Company

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:

Aug 20, 2020 06:00 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of STAAR Surgical Company (STAA) on Behalf of Investors

Law Offices of Howard G. Smith continues its investigation on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) investors concerning the Company’s possible violations of federal securities laws.

Aug 20, 2020 05:30 pm ET

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against STAAR Surgical Company

Federman & Sherwood announces that on August 19, 2020, a class action lawsuit was filed in the United States District Court for the Central District of California against STAAR Surgical Company (NASDAQ: STAA). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is February 26, 2020 through August 10, 2020.

Aug 20, 2020 04:00 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of STAAR Surgical Company (STAA) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 20, 2020 03:27 pm ET

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of STAAR Surgical Company (STAA) Investors

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 20, 2020 03:26 pm ET

STAAR Surgical Company Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP Announces that a Securities Class Action Lawsuit has been Filed on Behalf of Shareholders of STAAR Surgical Company

Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) announces that a federal securities class action lawsuit has been filed on behalf of shareholders of STAAR Surgical Company (NASDAQ: STAA) (“STAAR”) in the United States District Court...

Aug 20, 2020 01:00 pm ET

The Law Offices of Frank R. Cruz Continues Its Investigation of STAAR Surgical Company (STAA) on Behalf of Investors

The Law Offices of Frank R. Cruz continues its investigation on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 20, 2020 09:19 am ET

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against STAAR Surgical Company and Encourages Investors with Losses in Excess of $100,000 to Contact the F

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ:

Aug 19, 2020 08:00 pm ET

STAAR SURGICAL COMPANY ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against STAAR Surgical Company and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors that purchased STAAR Surgical Company (NASDAQ: STAA) common stock between February 26, 2020 and August 10, 2020 (the “Class Period”). Investors have until October 19, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Aug 19, 2020 02:54 pm ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against STAAR Surgical Company and Encourages Investors with Losses in Excess of $1,000,000 to Contact the

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ:

Aug 19, 2020 01:19 pm ET

Portnoy Law: Lawsuit Filed On Behalf of STAAR Surgical Company Investors

The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) investors that acquired shares between February 26, 2020 and August 10 2020....

Aug 19, 2020 11:05 am ET

LAWSUIT FILED: Block & Leviton LLP Announces that it Has Filed a Lawsuit Against STAAR Surgical Company for Securities Fraud; Investors Who Lost Money Should Contact the Firm

Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against STAAR Surgical Company (NASDAQ: STAA) and certain of its executives for...

Aug 19, 2020 10:57 am ET

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against STAAR Surgical Company and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or “the Company”) (NASDAQ:

Aug 19, 2020 08:00 am ET

STAAR Surgical Company Investors: Company Investigated by the Portnoy Law Firm

The Portnoy Law Firm advises STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. The...

Aug 18, 2020 05:00 pm ET

EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Announces Investigation of Securities Claims Against STAAR Surgical Company; Encourages Investors with Losses in Excess of $100K to Contact t

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of STAAR Surgical Company (NASDAQ: STAA) resulting from allegations that STAAR may have issued materially...

Aug 17, 2020 07:00 pm ET

STARR ALERT: Bragar Eagel & Squire, P.C. is Investigating STARR Surgical Company on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against STAAR Surgical Company (NASDAQ: STAA) on behalf of STAAR stockholders. Our investigation concerns whether STAAR has violated the federal securities laws and/or engaged in other unlawful business practices.

Aug 17, 2020 03:52 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages STAAR Surgical (STAA) Investors to Contact Its Attorneys Now, Firm Investigating Potential Improper Accounting and Securities Law Violations

Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. The firm is conducting a proprietary investigation into possible securities fraud. Relevant Holding Period: Before Aug. 11, 2020Visit:...

Aug 17, 2020 01:13 pm ET

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against STAAR Surgical Company and Encourages Investors with Losses of $100,000 to Contact the Firm

Aug 17, 2020 09:04 am ET

EQUITY ALERT: ROSEN, A LEADING AND RANKED LAW FIRM, Announces Investigation of Securities Claims Against STAAR Surgical Company – STAA

Aug 15, 2020 11:11 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company -STAA

Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...

Aug 14, 2020 12:00 pm ET

The Law Offices of Frank R. Cruz Announces Investigation of STAAR Surgical Company (STAA) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 14, 2020 09:12 am ET

SHAREHOLDER ALERT: Investigation of STAAR Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC is investigating whether STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) complied with federal securities laws. On August 11, 2020, J Capital published a report claiming the Company has overstated its sales in China. The price of STAAR’s stock fell following the announcement.

Aug 13, 2020 03:00 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of STAAR Surgical Company (STAA) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:

Aug 12, 2020 06:30 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of STAAR Surgical Company (STAA) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) investors concerning the Company’s possible violations of federal securities laws.

Aug 12, 2020 03:53 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages STAAR Surgical (STAA) Investors to Contact Its Attorneys Now, Firm Investigating Potential Improper Accounting and Securities Law Violations

Aug 05, 2020 04:01 pm ET

STAAR Surgical Reports Second Quarter 2020 Results

Jul 22, 2020 07:00 am ET

STAAR Surgical to Report Second Quarter Results on August 5, 2020

Jul 14, 2020 07:00 am ET

STAAR Surgical Company to Hold 2020 Annual Meeting of Shareholders in Virtual Format

STAAR Surgical Company (NASDAQ: STAA) today announced that to support the health and well-being of its shareholders, employees, directors, and communities due to the public health threat of the COVID-19 pandemic the Company’s upcoming 2020 Annual Meeting of Shareholders (the “Annual Meeting”) will be held in a virtual-only format. As previously announced, the Annual Meeting will be held on Thursday, July 30, 2020, at 8:30 a.m. PT, but shareholders will not be able to attend in person. The virtual meeting will provide shareholders the ability to participate, vote their shares, and ask questions

Jul 07, 2020 07:00 am ET

STAAR Surgical Introduces EVO Viva™ Presbyopia Correcting Lens – See Young Again!

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that EVO Viva™, STAAR’s innovative presbyopia correcting implantable Collamer® lens (“ICL”), has been approved for sale. STAAR received CE Mark approval of the presbyopic indication for its EVO+ Visian® ICL with Aspheric (EDOF) Optic, commercially marketed as “EVO Viva”, from its European Notified Body, DEKRA, on July 2, 2020. EVO Viva will initially be available to patients through sele

Jul 06, 2020 07:00 am ET

Patrick F. Williams Appointed Chief Financial Officer of STAAR Surgical

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Patrick F. Williams has joined the Company as Chief Financial Officer effective today. Mr. Williams is reporting to Caren Mason, President and Chief Executive Officer. His appointment is part of a planned transition following Deborah Andrews’ previously announced retirement. Ms. Andrews will continue in an advisory role to ensure a smooth transition of duties to Mr. Williams.

Jun 01, 2020 07:00 am ET

Dr. Gil Kliman and Tom Frinzi Appointed to STAAR Surgical Board of Directors

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointment of Gilbert H. Kliman, M.D., Managing Partner, InterWest Partners and Thomas G. Frinzi, former Worldwide President, Surgical, Johnson & Johnson Vision, to its Board of Directors, effective June 1, 2020. The appointment of Messrs. Kliman and Frinzi brings the total number of members on STAAR's Board to six.

May 06, 2020 04:01 pm ET

STAAR Surgical Reports First Quarter 2020 Results

Apr 15, 2020 07:00 am ET

STAAR Surgical to Report First Quarter Results on May 6, 2020

Apr 13, 2020 07:00 am ET

STAAR Surgical Provides COVID-19 Business Update

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to the evolving COVID-19 global health care concern.

Feb 26, 2020 04:01 pm ET

STAAR Surgical Reports Fourth Quarter and Full Year 2019 Results

Feb 05, 2020 07:05 am ET

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 26, 2020

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 3, 2020 on Wednesday, February 26, 2020 after the market close.

Feb 05, 2020 07:00 am ET

STAAR Surgical Announces Strategic Cooperation Agreement with Senshinkai Eye Institute, A Leading Eye Care Chain in Japan

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it entered a strategic cooperation agreement with Senshinkai Eye Institute (SEI), an eye care group with five locations in Japan. Like other strategic cooperation agreements, the agreement includes volume commitments for the Company’s implantable Collamer lenses (ICLs), ICL surgeon training and certification, tools for patient education and co-marketing.

Feb 04, 2020 07:00 am ET

STAAR Surgical Announces the EVO Implantable Lens US Clinical Trial is Underway with 1st Patient Implanted at Price Vision Group in Indianapolis on January 30th

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the first patient was implanted in the Company’s U.S. human clinical study for its EVO ICL family of lenses. The investigational study, “A Multicenter Clinical Evaluation of the EVO/EVO+ Visian® Implantable Collamer® Lens,” will be conducted at more than a dozen ophthalmology clinics across the United States. EVO Visian ICLs are intended to treat a wide range of refractive error, including myopia (nearsightedness) which i

Jan 13, 2020 07:01 am ET

STAAR Surgical Reports Preliminary Fourth Quarter Net Sales Growth of 25%

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the fourth quarter and fiscal year ended January 3, 2020. The Company expects fourth quarter and fiscal year net sales to increase approximately 25% and 21% over the prior year periods, respectively. Total net sales for the fourth quarter and fiscal year are expected to be approximately $38.9 million and $150.2 million, respectively, as compared to Company outlook for $37.6 million and $149.0 million most

Jan 13, 2020 07:00 am ET

STAAR Surgical Gains Supplemental Lens Approval for EVO Visian ICL to Target Post-Cataract Market Opportunity

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the Company has gained CE Mark approval for use of its ICL as a supplemental or “piggyback” lens in post-cataract IOL surgery patients (pseudophakics). A supplemental EVO ICL is placed in front of the cataract IOL lens in post-cataract patients just like the EVO ICL is placed in front of the human crystalline lens in refractive patients. The EVO ICL in the post-cataract patient is supplemental to the cataract IOL. The approv

Dec 18, 2019 04:05 pm ET

STAAR CFO to Retire in 2020

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that following a successful 24-year career with the Company, Deborah Andrews plans to retire from the company in 2020. Andrews will continue in her role as Chief Financial Officer until her successor is appointed, and then remain with the company during a transition period until her retirement.

Dec 17, 2019 07:00 am ET

STAAR Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced it has entered into a strategic alliance with the California Center for Refractive Surgery (CCRS), a Los Angeles based eye care group with locations in Hancock Park and Sherman Oaks.

Dec 11, 2019 07:00 am ET

STAAR Surgical Announces FDA IDE Clinical Study Approval

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that the FDA in a letter dated December 6, 2019, stated that it has determined that STAAR has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN® Implantable Collamer® Lens for Myopia, and EVO/EVO+ VISIAN® Toric Implantable Collamer® Lens for Myopia with Astigmatism.

Nov 06, 2019 07:00 am ET

STAAR Surgical to Host Investor and Analyst Day on November 8, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that the Company will host an Investor and Analyst Day on Friday, November 8, 2019 in New York City at 8:30 a.m. EST. The event will detail STAAR’s Vision for the 2020-2022 three-year planning period and include presentations by ophthalmic surgeons. Due to limited capacity, attendance at the Investor and Analyst Day is by invitation only.

Oct 30, 2019 04:01 pm ET

STAAR Surgical Reports Third Quarter Results

Oct 09, 2019 07:01 am ET

STAAR Surgical Celebrates Visual Freedom with Jorgensen Family

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr. Jorn S. Jorgensen successfully implanted the Company’s EVO Visian ICL in his son, Jannik Jorgensen, during a live-streamed event which also celebrated the opening of EuroEyes’ newest clinic. Dr. Jorgensen is the founder, chairman, executive director and CEO of the EuroEyes clinic group, with clinics across Germany, Denmark and China. A 3-minute video of father and son sharing thoughts leading up to the EVO ICL procedure

Oct 09, 2019 07:00 am ET

STAAR Surgical to Report Third Quarter Results on October 30, 2019

Sep 09, 2019 07:00 am ET

STAAR Surgical Announces EVO ICL Clinical Program for Its 16th Annual Surgical Experts Summit in Paris, France From September 11 – 13, 2019

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing the EVO ICL Clinical Program which will be presented by Ophthalmic Surgeons to Ophthalmic Surgeons at its invitation only Surgical Experts Summit. The Summit is expected to be attended by over 250 surgeons and invited clinician guests from forty-six countries. The Experts Summit will be held in Paris, France, directly ahead of the European Society of Cataract and Refractive Surgeons Meeting (ESCRS). Thirty-one surgeons will

Sep 04, 2019 07:00 am ET

STAAR Surgical Announces Strategic Alliance Agreement with Asian Eye Institute

Aug 27, 2019 07:00 am ET

STAAR Surgical Announces FDA IDE Clinical Study Approval

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that the FDA in a letter dated August 23, 2019, stated that it has determined that STAAR has provided sufficient data to support initiation of a human clinical study in the United States of the EVO/EVO+ VISIAN® Implantable Collamer® Lens for Myopia, and EVO/EVO+ VISIAN® Toric Implantable Collamer® Lens for Myopia with Astigmatism.

Jul 31, 2019 04:10 pm ET

STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance Vision

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the submission of its multi-site European pivotal clinical trial data for the EVO+ Visian® ICL with Aspheric (EDOF) Optic (“EDOF Lens”), a lens that is designed to provide correction or reduction of myopia or hyperopia and presbyopia (the age-related loss of near vision). Results from the clinical trial were submitted to DEKRA, the Company’s European Notified Body, earlier this month. If approved, STAAR’s EDOF lens could be comm

Jul 31, 2019 04:01 pm ET

STAAR Surgical Reports Record Second Quarter Results for Total Revenue, ICL Sales and ICL Units

Jul 10, 2019 07:00 am ET

You are here

STAAR Surgical Co (OQ:STAA)

Business Focus: Medical Equipment, Supplies & Distribution